Figure 2. CAT assessment post 14-days guaifenesin

From

Assessment and Treatment of Mucus Hypersecretion in COPD: A Case Study

Kami Whitney PA-C

American Journal of Medical Case Reports. 2021, 9(12), 730-733 doi:10.12691/ajmcr-9-12-18